These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24731838)

  • 1. Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD.
    Latella G; Rogler G; Bamias G; Breynaert C; Florholmen J; Pellino G; Reif S; Speca S; Lawrance IC
    J Crohns Colitis; 2014 Oct; 8(10):1147-65. PubMed ID: 24731838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the 4th scientific workshop of the ECCO (Group II): markers of intestinal fibrosis in inflammatory bowel disease.
    Rieder F; de Bruyn JR; Pham BT; Katsanos K; Annese V; Higgins PD; Magro F; Dotan I
    J Crohns Colitis; 2014 Oct; 8(10):1166-78. PubMed ID: 24726695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we prevent, reduce or reverse intestinal fibrosis in IBD?
    Latella G; Sferra R; Speca S; Vetuschi A; Gaudio E
    Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1283-304. PubMed ID: 23740440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease.
    Siegmund B; Feakins RM; Barmias G; Ludvig JC; Teixeira FV; Rogler G; Scharl M
    J Crohns Colitis; 2016 Apr; 10(4):377-86. PubMed ID: 26681764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of initiation and progression of intestinal fibrosis in IBD.
    Latella G; Di Gregorio J; Flati V; Rieder F; Lawrance IC
    Scand J Gastroenterol; 2015 Jan; 50(1):53-65. PubMed ID: 25523556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the intestinal microbiota and fecal transplantation in inflammatory bowel diseases.
    Liang J; Sha SM; Wu KC
    J Dig Dis; 2014 Dec; 15(12):641-6. PubMed ID: 25389085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of the 2nd scientific workshop of the ECCO (III): basic mechanisms of intestinal healing.
    Rieder F; Karrasch T; Ben-Horin S; Schirbel A; Ehehalt R; Wehkamp J; de Haar C; Velin D; Latella G; Scaldaferri F; Rogler G; Higgins P; Sans M
    J Crohns Colitis; 2012 Apr; 6(3):373-85. PubMed ID: 22405177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn's disease.
    Zorzi F; Calabrese E; Monteleone G
    Clin Sci (Lond); 2015 Dec; 129(12):1107-13. PubMed ID: 26494636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease.
    Mäkitalo L; Kolho KL; Karikoski R; Anthoni H; Saarialho-Kere U
    Scand J Gastroenterol; 2010 Aug; 45(7-8):862-71. PubMed ID: 20367198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrigenomics and IBD: the intestinal microbiota at the cross-road between inflammation and metabolism.
    Haller D
    J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S6-9. PubMed ID: 20535026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of tissue remodeling in inflammatory bowel disease.
    Rieder F; Fiocchi C
    Dig Dis; 2013; 31(2):186-93. PubMed ID: 24030223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota.
    Ihara S; Hirata Y; Koike K
    J Gastroenterol; 2017 Jul; 52(7):777-787. PubMed ID: 28534191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases in intestinal fibrosis.
    Biel C; Faber KN; Bank RA; Olinga P
    J Crohns Colitis; 2024 Mar; 18(3):462-478. PubMed ID: 37878770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Autophagy in the Maintenance of Intestinal Homeostasis.
    Baxt LA; Xavier RJ
    Gastroenterology; 2015 Sep; 149(3):553-62. PubMed ID: 26170139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases.
    de Bruyn M; Vandooren J; Ugarte-Berzal E; Arijs I; Vermeire S; Opdenakker G
    Crit Rev Biochem Mol Biol; 2016 Sep; 51(5):295-358. PubMed ID: 27362691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Features of intestinal lesions in the clinical course of inflammatory bowel diseases.
    Vetuschi A; Latella G; Pompili S; Gaudio E; Sferra R
    Ital J Anat Embryol; 2014; 119(3):286-303. PubMed ID: 26749690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenium and inflammatory bowel disease.
    Kudva AK; Shay AE; Prabhu KS
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(2):G71-7. PubMed ID: 26045617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease.
    Lovisa S; Genovese G; Danese S
    J Crohns Colitis; 2019 Apr; 13(5):659-668. PubMed ID: 30520951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication.
    Bettenworth D; Rieder F
    Dig Dis; 2017; 35(1-2):25-31. PubMed ID: 28147352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease.
    Bamias G; Pizarro TT; Cominelli F
    Inflamm Bowel Dis; 2022 Mar; 28(3):337-349. PubMed ID: 34904152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.